A Day Up For Adaptimmune Therapeutics plc

Thu, Sep 18, 2025 at 08:00 PM

Adaptimmune Therapeutics plc (ADAP:NASDAQ) soared at $0.16, representing a gain of 98%. On Thu, Sep 18, 2025, ADAP:NASDAQ hit a New 2-Week High of $0.16. From Thu, Sep 04, 2025, the stock recorded 40.00% Up Days and 18.18% Green Days

The stock spiked on Thu, Jul 24, 2025 at $0.36 with a volume of 3M+.

About Adaptimmune Therapeutics plc (ADAP:NASDAQ)

Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.

Top 10 Gainers:

Brera Holdings PLC (BREA:NASDAQ), 225.49%
Adaptimmune Therapeutics plc (ADAP:NASDAQ), 98.02%
Cardlytics, Inc. (CDLX:NASDAQ), 92.66%
89bio, Inc. (ETNB:NASDAQ), 85.15%
SRAX, Inc. (SRAX:NASDAQ), 75%
Laser Photonics Corporation (LASE:NASDAQ), 68.21%
Aeries Technology, Inc (AERT:NASDAQ), 63.85%
Psyence Biomedical Ltd. (PBM:NASDAQ), 42.47%
Aptevo Therapeutics Inc. (APVO:NASDAQ), 40.43%
Robot Consulting Co. Ltd. (LAWR:NASDAQ), 35.64%